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Abstract This study aimed to determine whether primary
surgical closure of patent ductus arteriosus (PDA) is a risk
factor for morbidity and mortality compared with secondary
surgical ligation. The study enrolled 178 very-low-birth-
weight infants. The surgical group included 34 patients who
did not respond to pharmacologic intervention and eventually
required ligation of their PDA as well as 35 patients who
underwent direct ligation because of contraindications to the
use of oral ibuprofen. The overall outcomes for the primary
and secondary ligation groups were compared. The outcome
during hospitalization showed no statistically significant dif-
ference in terms of morbidity and mortality between the two
groups. The group that had primary ligation for PDA experi-
enced more complications associated with premature birth
such as lower gestational age and birth weight. The two groups
did not differ significantly in terms of overall outcomes.
Keywords Surgical ligation  Morbidity 
Hemodynamically significant ductus arteriosus
Introduction
Persistent hemodynamically significant ductus arteriosus
(HSDA) is considered to be closed, although routine
treatment to close a persistently patent ductus arteriosus
(PDA) in premature infants is no longer recommended [2,
10]. However, HSDA leads to clinical complications such
as pulmonary hemorrhage, bronchopulmonary dysplasia
(BPD), necrotizing enterocolitis (NEC), renal impairment,
intraventricular hemorrhage (IVH), periventricular leuko-
malacia, cerebral palsy, and death [2].
Moderate to large left-to-right PDA shunts alter pulmonary
mechanics and decrease alveolarization, which results in
difficulty weaning the patient off a ventilator [10]. NEC and
acute renal failure (ARF) are frequently reported postnatal
morbidities that result from pulmonary overcirculation, which
is caused by the ‘‘ductal steal’’ phenomenon [18, 23].
The benefits of surgical ligation for the brain and kid-
neys and the resulting positive effects on NEC in HSDA
patients have been reported [16, 21]. As a result, the
morbidities associated with HSDA require that clinicians
promptly close HSDA with either medication or surgical
ligation.
Surgical ligation frequently is the treatment of choice
for very-low-birth-weight (VLBW) infants vulnerable to
the side effects of cyclooxygenase (COX) inhibitors who
are unlikely to experience successful closure with medi-
cation. Prostaglandin synthetase inhibitors [6] have a
30–40 % failure rate, and COX inhibitors cannot be pre-
scribed for all patients. Therefore, surgical ligation often is
performed after medical treatment failure but also can be
performed as the first line of treatment.
With increasing awareness of HSDA closure, our center
realized that our target population should be refined such
that all patients have HSDA to improve the success rate of
surgical intervention. At our center, we adapted the HSDA
criterion based on the proposed clinical and echocardiog-
raphy staging system developed by McNamara and Sehgal
[14]. After the HSDA diagnosis, early intervention to close
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PDA helps to reduce the time of HSDA exposure and
minimize the complications associated with PDA.
At our center, patients usually are stabilized and can tol-
erate weaning off the ventilator and advancement of feeding
well within 3 days after surgical ligation of PDA. We com-
pared the overall outcomes between VLBW infants who
underwent primary ligation and those who had secondary
ligation. This study aimed to evaluate the outcomes in the
two HSDA groups during their admission periods.
Materials and Methods
Between 1 November 2010 and 1 September 2012, 178
VLBW infants were admitted to the Neonatal Intensive
Care Unit (NICU) of Seoul St. Mary’s Hospital, the
Catholic University of Korea. These infants were enrolled
prospectively in this study. Clinical information related to
both the presence and treatment of PDA as well as treat-
ment outcomes was collected.
The VLBW infants were screened for PDA within the first
4 days of life, and their diagnosis was confirmed with a two-
dimensional echocardiogram. Our target for treatment
included infants with at least moderate-stage HSDA (stage
C3) based on the clinical and echocardiographic criteria
developed by McNamara and Sehgal [14]. The VLBW
infants with complex congenital heart disease or right-to-left
or bidirectional PDA shunting were excluded from the study.
Medical failure was defined as consistent HSDA (stage
C3) after two courses of oral ibuprofen, a large PDA
(4 mm), or any contraindications after the first course of
oral ibuprofen treatment. The inclusion criteria for this
study specified VLBW infants with at least a moderate
stage of HSDA (stage C3) based on the clinical and
echocardiographic criteria developed by McNamara and
Sehgal [14] who could not be treated pharmacologically
due to various clinical contraindications.
When pharmacologically indicated, oral ibuprofen was
prescribed at 10 mg/kg as a base dose, followed by two
additional doses of 5 mg/kg on consecutive days [1, 17].
A PDA surgical ligation was routinely performed at the
bedside in the NICU, and all ligations were performed by
the same experienced pediatric cardiac surgeon using a
metal clip through the third or fourth intercostal space after
posterolateral thoracotomy. The procedure required a mean
time of 51 min. The study was approved by the Ethics
Committee of Seoul St. Mary’s Hospital.
Definitions
By definition, mild apnea involves episodes of oxygen
desaturation, bradycardia or apnea fewer than six times a
day, and moderate apnea involves hourly episodes of
oxygen desaturation, bradycardia, or apnea [14]. BPD is
defined as the use of oxygen exceeding 0.21 % at a cor-
rected gestational age of 36 weeks, at discharge to home of
infants born before 32 weeks of gestational age, or at a
postnatal age of more than 28 days but less than 56 days
for infants born after 32 weeks of gestational age.
Necrotizing enterocolitis, using Bell’s classification, is
defined as grade 1 or higher. The treatment of NEC consists
of feeding restriction and administration of antibiotics. Oli-
guria is defined as a urine output exceeding 1 ml/kg/h, and
ARF is defined as a sustained decrease in urine output with
serum creatinine increased to 1.5 mg/dl or more. IVH is
defined as current bleeding in the ventricles (grade C2) using
the classification constructed by Drs. Papile and Levene.
Retinopathy of prematurity (ROP) in this study was defined
as neovascular tufts found posterior to the ridge and classi-
fied higher than stage 3 according to the International Clas-
sification of Diseases for ROP.
Statistical Analysis
Continuous variables were compared using Student’s t test
and are expressed as means ± standard deviations. Dis-
crete variables were compared using a v2 test or Fisher’s
exact test and are expressed as percentages. All the anal-
yses were two-tailed, and clinical significance was defined
as a p value lower than 0.05.
For potential differences in neonatal morbidities
between the two groups, we used a multivariate logistic
regression model. Odds ratios (ORs) and 95 % confidence
intervals (CI) were calculated using a multivariate statis-
tical model that included the following predictors related to
hospital outcomes with a stepwise logistic regression ana-
lysis: birth weight (1,000 g) and gestational age
(\27 weeks). All the statistical analyses were performed
with the Statistical Package for the Social Sciences (SPSS),
version 15.0 (SPSS-PC Inc., Chicago, IL, USA).
Results
Demographic Data
Ibuprofen treatment was effective for 109 (61 %) of the
178 infants, but the remaining 69 patients (39 %) required
surgical ligation. The surgical group of 69 patients con-
sisted of the 34 patients who did not respond to ibuprofen
and the 35 patients directly ligated because of contraindi-
cations to the use of oral ibuprofen. In the group treated
with ibuprofen, 25 infants (71 %) received one course of
ibuprofen, and 10 (29 %) were treated with two courses.
The 35 infants directly ligated because of contraindications
to oral ibuprofen had bleeding tendencies (positive DIC;
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n = 21), evolving severe IVH (grade C3; n = 7), large
PDA ([4 mm; n = 3), poor urine output (\1 ml/kg/h;
n = 2), and ARF (n = 2).
Clinical data were compared between the two groups
(Table 1). The gestational age (27.3 vs 29.2; p \ 0.048)
and birth weight (1.02 vs 1.19; p \ 0.037) were signifi-
cantly lower only in primary surgical group. Males out-
numbered females in both groups (0.56 vs 0.52).
The initial PDA shunt size was approximately 2 mm,
but it was larger (*3 mm) at the time of ligation. How-
ever, the initial PDA shunt size and the PDA size at the
time of ligation did not differ significantly between the two
groups. Additionally, the median duration of admission,
ventilation, and oxygen did not differ significantly between
the two groups. The mean age at the time of ligation was
14.5 days in the primary ligation group and 20.5 days in
the secondary ligation group.
Primary Versus Secondary Ligation
The outcome during hospitalization showed no statistically
significant difference in the rates of BPD, NEC (grade C1),
ARF, IVH (grade C2), periventricular leukomalacia, ROP,
culture-proven sepsis, or mortality between the two groups
(Table 2). No immediate intraoperative complications such
as vocal cord paralysis, hemorrhage, air leaks, wound
infection [11], or chylothorax were noted in either group.
All the infants were ventilated at the time of ligation.
Severe IVH (grades 3 and 4) was diagnosed for seven
infants (20 %) in the primary ligation group, compared
with five infants (15 %) in the secondary ligation group,
but the difference between the two groups was not signif-
icant. In addition, the two groups did not differ signifi-
cantly in terms of increase in ventilation, fraction of
inspired oxygen (FiO2), or pressor requirement in the 48 h
after ligation. Additionally, the findings showed no sig-
nificant difference in the incidence of postoperative com-
plications. At the time of NICU discharge, the two groups
did not differ significantly with regard to rates of mortality,
moderate to severe BPD (41 vs 29 %), ROP (31 vs 29 %),
or NEC (31 vs 32 %) (Table 2).
Short-Term Outcomes After Surgical Ligation
The primary reasons for ligation were pulmonary edema or
cardiomegaly shown by radiology (n = 28, 40 %), an
increasing requirement for ventilation (n = 25, 36 %),
systemic hypotension requiring at least a single cardio-
tropic agent (n = 20, 29 %) that could not be explained by
other causes, hourly episodes of oxygen desaturation
(n = 26, 38 %), and/or mild metabolic acidosis (pH
7.1–7.25 and/or base deficit of -7 to -12) (n = 18, 26 %).
The infants born at 24–27 weeks of gestation were more
likely to meet the criteria for ligation (92 %) than those
born after 27 weeks of gestation (56 %). Of the patients
with moderate apnea, 30 (43 %) improved to mild apnea
with occasional (\6) episodes of oxygen desaturation or
bradycardia [14]. A majority of the patients (93 %) were
Table 1 Clinical characteristics of the primary ligation group versus









192.88 ± 21.88 203.24 ± 17.84 0.048a







Males, n (%) 14 (40.0) 18 (53.0) 0.773
RDS, n (%) 30 (85.7) 31 (91.2) 0.286
PDA shunt size at
initiation (mm)
2.16 ± 1.08 2.04 ± 1.10 0.342
PDA shunt size at
ligation (mm)
3.16 ± 1.38 3.24 ± 1.10 0.482
Duration of
admission (days)
70.96 ± 44.75 66.19 ± 30.25 0.655
Duration of MV
(days)
39.85 ± 33.26 32.35 ± 28.47 0.352
Duration of O2
therapy (days)
57.58 ± 44.21 54.21 ± 33.80 0.739
RDS respiratory distress syndrome, PDA patent ductus arteriosus, MV
mechanical ventilation, O2 oxygen
a Fisher’s exact test







CLD 19 (73.1 %) 25 (73.5 %) 0.969
Severe CLD 12 (41.4 %) 10 (29.4 %) 0.826
NEC (grade
C1)
8 (30.8 %) 11(32.4 %) 0.896
ARF 14 (53.8 %) 12 (35.3 %) 0.151
IVH (grade
C2)
19 (73.1 %) 21 (61.8 %) 0.357
ROP 8 (30.8 %) 10 (29.4 %) 0.909
PVL 5 (19.2 %) 5 (14.7 %) 0.641
Sepsis 14 (53.8 %) 15 (44.1 %) 0.455
Death 5 (14 %) 3 (9 %) 0.072
CLD chronic lung disease, NEC necrotizing enterocolitis, ARF acute
renal failure, IVH intraventricular hemorrhage, ROP retinopathy of
prematurity, PVL periventricular leukomalacia
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able to continue enteral feedings and increased their
feeding amounts (10–20 ml/kg/day) 3 days after ligation.
The oliguria experienced by 50 of the infants (72 %) was
resolved by day 3 after ligation. Although the group with
primary surgical closure of PDA had more impairments
related to immaturity than the group that had secondary
surgical closure, no differences in the rates of morbidity or
mortality were found based on our logistic regression
analysis during hospitalization (Table 3).
Discussion
In this study, the PDA group with primary surgical ligation
experienced more complications related to premature birth,
such as gestational age and birth weight. However, the two
groups did not differ significantly in overall outcomes.
The use of prostaglandin synthetase inhibitor for PDA
has a 30–40 % failure rate [6], and 40 % of the patients are
unlikely to respond to indomethacin therapy [4, 13, 20].
Our failure rate for oral ibuprofen was similarly 39 %.
Infants who are more premature and weigh less also
have a higher prostaglandin synthetase inhibitor failure rate
[19]. The reported complications include pulmonary
bleeding, NEC, intestinal perforation, renal failure, and
thrombocytopenia, especially in low-birth-weight preterm
neonates. Therefore, prostaglandin synthetase inhibitors are
used with great caution for VLBW infants and may even
worsen already compromised intestinal blood flow in the
presence of a hemodynamically significant PDA [26].
Additional studies also have proved that treatment fail-
ure is associated with low birth weight (\1,500 g) and
severe cardiopulmonary compromise [22, 27]. Mellander
et al. [15] found that pharmacologic failure for neonates
with cardiopulmonary compromise results in prolonged
ventilator support after surgical ligation of their ductus.
Because surgical ligation is an effective and definite
procedure associated with low mortality, when indicated,
timed ligation without delay of the HSDA exposure period
for VLBW infants may be considered. The optimal timing
for surgical ligation is debatable. The study by Lee et al.
[12] performed in the United Kingdom showed an associ-
ation between multiple courses of COIs before PDA liga-
tion and an increased incidence of chronic lung disease.
A similar trend in the data associated with delayed
ligation raises the possibility that earlier treatment could be
advantageous [7]. The patients referred early for ligation
had evidence of improved respiratory outcomes [7]. Early
surgical closure, compared with late closure, is associated
with improved short-term ventilator parameters and pul-
monary function, more rapid advancement to full oral
feeding, and healthier body growth [24]. Jaillard et al. [8]
studied the consequences of delayed surgical closure of
PDA in very premature infants and concluded that early
surgical closure of the ductus arteriosus (at \3 weeks of
life) is associated with a shortened delay in full oral feeding
and improved body growth compared with late surgical
closure (at [3 weeks of life). The optimal timing of liga-
tion may depend not only on postnatal age (at less than
3 weeks of life) but also on when the HSDA develops and
how long the significant ductus arteriosus exposes and
hemodynamically affects related organs.
In general, pulmonary overcirculation may lead to
considerable morbidities involving CLD, NEC, and renal
impairment due to the ‘‘ductal steal’’ phenomenon. A
recent study of premature baboons showed altered pul-
monary mechanics and arrested alveolarization after
14 days of exposure to moderate-sized ductus [3]. Over-
circulation to the lungs in humans also can interfere with
the adequate development of premature lungs and could
result in microcirculatory lung damage [25].
Two small randomized controlled trials performed
almost 30 years ago were designed to examine the effects
of a persistent symptomatic PDA on neonatal pulmonary
morbidity [5, 9]. Both studies found that surgical closure of
PDA decreased the need for prolonged ventilator support,
whereas significant pulmonary morbidity occurred for
patients without PDA ligation when signs of congestive
failure developed [5, 9]. Benitz [2] additionally suggested
that delayed ductal closure in premature infants is a
reflection of an underlying process, such as systemic
inflammation, that contributes to various morbidities in
addition to the associated large left-to-right ductal shunt-
ing. They further mention that a particular class of treat-
ments (intervention to close the PDA) that fail to improve
outcomes does not mean that no treatment is useful or
necessary or that the PDA can simply be ignored [2].
In conclusion, when HSDA is found in VLBW infants
and needs to be closed, timed ligation may be beneficial for
Table 3 Effects on neonatal morbidity and mortality in the primary
ligation group versus the secondary ligation group
Morbidity OR 95 % CI p value
CLD 0.171 0.396–5.141 0.587
NEC (grade C1) 1.920 0.525–7.019 0.324
ARF 0.718 0.215–2.404 0.289
IVH (grade C2) 1.001 0.269–3.722 0.999
ROP 1.474 0.392–5.544 0.566
PVL 0.972 0.215–4.400 0.970
Sepsis 1.018 0.327–3.167 0.976
Death 0.283 0.075–1.953 0.248
OR odds ratio, CI confidence interval, CLD chronic lung disease,
NEC necrotizing enterocolitis, ARF acute renal failure, IVH intra-
ventricular hemorrhage, ROP retinopathy of prematurity, PVL peri-
ventricular leukomalacia
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reducing pulmonary, renal, and intestinal morbidities. The
optimal timing of surgical ligation in the case of HSDA is
as early as possible according to the proposed clinical and
echocardiography staging system developed by McNamara
and Sehgal [14].
Our study demonstrated that primary ligation is safe,
without postoperative complications, and that the risks
after HSDA exposure, which can cause IVH, NEC, CLD,
and increased mortality in VLBW infants, might be
reduced. Ligation of PDA also was associated with short-
term respiratory and feeding improvements in our study.
Careful patient selection with prompt intervention may be
needed, and timely ligation for PDA can be an ideal
treatment method for HSDA when pharmacologic inter-
ventions are unsuccessful.
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